23andMe Investor Presentation Deck slide image

23andMe Investor Presentation Deck

We Pioneered Digital DTC Healthcare to Empower Customers With Affordable, Direct Access ¹ See FDA De Novo Authorizations 140044, 160026, 170046 and 180028 and FDA 510K Clearances K182784 and K193492. 8 FDA Authorizations/ Clearances TIME MAGAZINE INVENTION OF THE YEAR 1. The Retail DNA Test By Anita Hamilton Wednesday, Oct. 29, 2008 Best Inventions of 2008 > From a genetic testing service to an invisibility cloak to an ingenious public bike system to the world's first moving skyscraper - here are TIME's picks for the top innovations of 2008 Proven accuracy (99% NPV/PPV) and accessibility¹ 2015 2016 2017 2018 2019 Carrier Status (inherited conditions) GHR (genetic health risk) BRCA (breast and ovarian cancer) PGt (pharmacogenetic metabolism) MUTYH (colorectal cancer) 2020 PGt (pharmacogenetic drug response) 2022 HOXB13 (prostate cancer) 2022 Simvastatin (cholesterol PGt)
View entire presentation